Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
NCT01590758
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
189
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Foot Infection
Interventions
DRUG:
Topical pexiganan cream 0.8%
DRUG:
Topical placebo cream
OTHER:
Standard wound care
Sponsor
Dipexium Pharmaceuticals, Inc.